Cabaletta Bio Ownership | Who Owns Cabaletta Bio?

Overview Forecast RevenueFinancials Chart

Cabaletta Bio Ownership Summary

Cabaletta Bio is owned by 98.18% institutional investors, 3.10% insiders. Blackrock is the largest institutional shareholder, holding 9.65% of CABA shares. Alger Small Cap Focus I is the top mutual fund, with 4.76% of its assets in Cabaletta Bio shares.

CABA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cabaletta Bio	98.18%	3.10%	-1.28%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	4.76M	9.65%	$35.58M
T. rowe price investment management	3.88M	7.87%	$29.01M
Adage capital partners gp	3.04M	6.16%	$22.71M
Jennison associates	2.51M	5.13%	$5.70M
Fred alger management	2.52M	5.12%	$18.87M
Vanguard group	2.37M	4.80%	$17.70M
State street	2.01M	4.07%	$15.00M
Bain capital life sciences investors	1.65M	3.35%	$12.34M
Vr adviser	1.56M	3.17%	$11.70M
Sofinnova investments	1.22M	2.48%	$9.13M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bain capital life sciences investors	1.65M	1.35%	$12.34M
Superstring capital management lp	139.90K	1.32%	$1.05M
Vr adviser	1.56M	0.74%	$11.70M
Commodore capital lp	1.10M	0.56%	$8.23M
Sofinnova investments	1.22M	0.47%	$9.13M
Integral health asset management	425.00K	0.30%	$3.18M
Healthinvest partners ab	64.32K	0.29%	$481.12K
Redmile group	442.83K	0.20%	$3.31M
Corton capital	31.93K	0.13%	$238.84K
E fund management	286.42K	0.12%	$2.14M

Top Buyers

Holder	Shares	% Assets	Change
T. rowe price investment management	3.88M	0.02%	1.41M
Jpmorgan chase	956.69K	0.00%	933.03K
Sofinnova investments	1.22M	0.47%	790.65K
Blackrock	4.76M	0.00%	699.11K
Ubs asset management americas	403.14K	0.00%	390.21K

Top Sellers

Holder	Shares	% Assets	Change
Jennison associates	2.51M	0.00%	-3.12M
Alkeon capital management	-	-	-2.62M
State street	2.01M	0.00%	-1.74M
Polar capital	-	-	-1.25M
Cormorant asset management, lp	-	-	-1.10M

New Positions

Holder	Shares	% Assets	Change	Value
Panagora asset management	299.80K	0.01%	299.80K	$2.24M
Walleye capital	189.96K	0.00%	189.96K	$1.42M
Jump financial	182.13K	0.03%	182.13K	$1.36M
Two sigma advisers, lp	72.50K	0.00%	72.50K	$542.30K
Corton capital	31.93K	0.13%	31.93K	$238.84K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-7.00
Gamma investing	-12.00
Eversource wealth advisors	-72.00
Capital advisors	-81.00
Cibc private wealth group	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	120	-15.49%	48,049,085	-5.40%	98	0.93%	65	-7.14%	33	-32.65%
Jun 30, 2024	142	-14.97%	50,793,811	-0.49%	103	0.96%	70	-21.35%	49	2.08%
Mar 31, 2024	167	22.79%	51,041,400	5.15%	103	0.74%	89	5.95%	48	54.84%
Dec 31, 2023	136	34.65%	48,539,644	18.67%	118	1.37%	84	16.67%	31	158.33%
Sep 30, 2023	101	14.77%	40,903,603	12.25%	93	1.08%	72	20.00%	12	-14.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Alger Small Cap Focus I	2.33M	4.76%	-266.34K
Alger Small Cap Focus Composite	2.33M	4.76%	-266.34K
T. Rowe Price Small-Cap Value	1.93M	3.95%	-
Vanguard Total Stock Mkt Idx Inv	1.40M	2.87%	-
Jennison Health Sciences Equity	1.38M	2.82%	-
PGIM Jennison Health Sciences Z	1.38M	2.82%	-
PGIM Jennison Small Company A	1.29M	2.63%	-
Jennison SMid Cap Core Equity	1.29M	2.63%	-
iShares Russell 2000 ETF	1.17M	2.39%	-4.47K
T. Rowe Price U.S. SC Value Eq Tr-Z	1.06M	2.17%	4.06K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 19, 2024	Binder Gwendolyn	See Remarks	Sell	$14.23K
Jan 19, 2024	Binder Gwendolyn	See Remarks	Sell	$201.21K
Dec 19, 2023	Binder Gwendolyn	See Remarks	Sell	$171.20K
Dec 19, 2023	Binder Gwendolyn	See Remarks	Sell	$69.59K
Nov 20, 2023	Binder Gwendolyn	See Remarks	Sell	$61.61K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	2
2023 Q4	-	6
2023 Q3	-	6
2023 Q2	-	2

CABA Ownership FAQ

Who Owns Cabaletta Bio?

Cabaletta Bio shareholders are primarily institutional investors at 98.18%, followed by 3.10% insiders and -1.28% retail investors. The average institutional ownership in Cabaletta Bio's industry, Biotech Stocks , is 109.70%, which Cabaletta Bio falls below.

Who owns the most shares of Cabaletta Bio?

Cabaletta Bio’s largest shareholders are Blackrock (4.76M shares, 9.65%), T. rowe price investment management (3.88M shares, 7.87%), and Adage capital partners gp (3.04M shares, 6.16%). Together, they hold 23.67% of Cabaletta Bio’s total shares outstanding.

Does Blackrock own Cabaletta Bio?

Yes, BlackRock owns 9.65% of Cabaletta Bio, totaling 4.76M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.58M$. In the last quarter, BlackRock increased its holdings by 699.11K shares, a 17.23% change.

Who is Cabaletta Bio’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Cabaletta Bio’s biggest shareholder by percentage of total assets invested, with 1.35% of its assets in 1.65M Cabaletta Bio shares, valued at 12.34M$.

Who is the top mutual fund holder of Cabaletta Bio shares?

Alger Small Cap Focus I is the top mutual fund holder of Cabaletta Bio shares, with 4.76% of its total shares outstanding invested in 2.33M Cabaletta Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools